Prions: Protein Aggregation and Infectious Diseases - Physiological ...

More documents

Recommendations

Info

1148 ADRIANO AGUZZI AND ANNA MARIA CALELLA volves autonomic fibers of the splanchnic and vagus nerves. J Virol 75: 9320–9327, 2001. 337. McKinley MP, Bolton DC, Prusiner SB. A protease-resistant protein is a structural component of the scrapie prion. Cell 35: 57–62, 1983. 338. McKinley MP, Meyer RK, Kenaga L, Rahbar F, Cotter R, Serban A, Prusiner SB. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol 65: 1340–1351, 1991. 339. Mead S. Prion disease genetics. Eur J Hum Genet 14: 273–281, 2006. 340. Mead S, Poulter M, Uphill J, Beck J, Whitfield J, Webb TE, Campbell T, Adamson G, Deriziotis P, Tabrizi SJ, Hummerich H, Verzilli C, Alpers MP, Whittaker JC, Collinge J. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol 8: 57–66, 2009. 341. Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, Campbell T, Uphill JB, Goldstein D, Alpers M, Fisher EM, Collinge J. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300: 640–643, 2003. 342. Meggendorfer F. Klinische und genealogische Beobachtungen bei einem Fall von spastischer Pseudosklerose Jakobs. Z Ges Neurol Psychiatr 128: 337–341, 1930. 343. Meier P, Genoud N, Prinz M, Maissen M, Rulicke T, Zurbriggen A, Raeber AJ, Aguzzi A. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease. Cell 113: 49–60, 2003. 344. Merz PA, Somerville RA, Wisniewski HM, Manuelidis L, Manuelidis EE. Scrapie-associated fibrils in Creutzfeldt-Jakob disease. Nature 306: 474–476, 1983. 345. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret JM, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313: 1781–1784, 2006. 346. Meyer RK, McKinley MP, Bowman KA, Braunfeld MB, Barry RA, Prusiner SB. Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci USA 83: 2310–2314, 1986. 347. Miele G, Seeger H, Marino D, Eberhard R, Heikenwalder M, Stoeck K, Basagni M, Knight R, Green A, Chianini F, Wuthrich RP, Hock C, Zerr I, Aguzzi A. Urinary alpha1-antichymotrypsin: a biomarker of prion infection. PLoS ONE 3: e3870, 2008. 348. Miller MW, Williams ES. Prion disease: horizontal prion transmission in mule deer. Nature 425: 35–36, 2003. 349. Miller MW, Williams ES, Hobbs NT, Wolfe LL. Environmental sources of prion transmission in mule deer. Emerg Infect Dis 10: 1003–1006, 2004. 350. Millson GC, Hunter GD, Kimberlin RH. An experimental examination of the scrapie agent in cell membrane mixtures. II. The association of scrapie activity with membrane fractions. J Comp Pathol 81: 255–265, 1971. 351. Mishra RS, Basu S, Gu Y, Luo X, Zou WQ, Mishra R, Li R, Chen SG, Gambetti P, Fujioka H, Singh N. Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J Neurosci 24: 11280–11290, 2004. 352. Moechars D, Dewachter I, Lorent K, Reverse D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, Van Leuven F. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274: 6483–6492, 1999. 353. Mohan J, Brown KL, Farquhar CF, Bruce ME, Mabbott NA. Scrapie transmission following exposure through the skin is dependent on follicular dendritic cells in lymphoid tissues. J Dermatol Sci 35: 101–111, 2004. 354. Montrasio F, Cozzio A, Flechsig E, Rossi D, Klein MA, Rulicke T, Raeber AJ, Vosshenrich CA, Proft J, Aguzzi A, Weissmann C. B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice. Proc Natl Acad Sci USA 98: 4034–4037, 2001. Physiol Rev VOL 89 OCTOBER 2009 www.prv.org 355. Montrasio F, Frigg R, Glatzel M, Klein MA, Mackay F, Aguzzi A, Weissmann C. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288: 1257–1259, 2000. 356. Moore RC, Lee IY, Silverman GL, Harrison PM, Strome R, Heinrich C, Karunaratne A, Pasternak SH, Chishti MA, Liang Y, Mastrangelo P, Wang K, Smit AF, Katamine S, Carlson GA, Cohen FE, Prusiner SB, Melton DW, Tremblay P, Hood LE, Westaway D. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol 292: 797–817, 1999. 357. Morel E, Andrieu T, Casagrande F, Gauczynski S, Weiss S, Grassi J, Rousset M, Dormont D, Chambaz J. Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor. Am J Pathol 167: 1033–1042, 2005. 358. Moroncini G, Mangieri M, Morbin M, Mazzoleni G, Ghetti B, Gabrielli A, Williamson RA, Giaccone G, Tagliavini F. Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody. Neurobiol Dis 23: 717–724, 2006. 359. Munson L, Terio KA, Worley M, Jago M, Bagot-Smith A, Marker L. Extrinsic factors significantly affect patterns of disease in free-ranging and captive cheetah (Acinonyx jubatus) populations. J Wildl Dis 41: 542–548, 2005. 360. Muramoto T, DeArmond SJ, Scott M, Telling GC, Cohen FE, Prusiner SB. Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an alphahelix. Nat Med 3: 750–755, 1997. 361. Muramoto T, Scott M, Cohen FE, Prusiner SB. Recombinant Scrapie-like prion protein of 106 amino acids is soluble. Proc Natl Acad Sci USA 93: 15457–15462, 1996. 362. Naslavsky N, Stein R, Yanai A, Friedlander G, Taraboulos A. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem 272: 6324–6331, 1997. 363. Neutra MR, Frey A, Kraehenbuhl JP. Epithelial M cells: gateways for mucosal infection and immunization. Cell 86: 345–348, 1996. 364. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, Naslund J, Lannfelt L. The “Arctic” APP mutation (E693G) causes Alzheimer’s disease by enhanced Abeta protofibril formation. Nat Neurosci 4: 887–893, 2001. 365. Nilsson KP, Aslund A, Berg I, Nystrom S, Konradsson P, Herland A, Inganas O, Stabo-Eeg F, Lindgren M, Westermark GT, Lannfelt L, Nilsson LN, Hammarstrom P. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer’s disease using novel luminescent probes. ACS Chem Biol 2: 553–560, 2007. 366. Nilsson KPR, Hammarstrom P, Ahlgren F, Herland A, Schnell EA, Lindgren M, Westermark GT, Inganas O. Conjugated polyelectrolytes-conformation-sensitive optical probes for staining and characterization of amyloid deposits. Chembiochem 7: 1096–1104, 2006. 367. Nilsson KPR, Herland A, Hammarstrom P, Inganas O. Conjugated polyelectrolytes: conformation-sensitive optical probes for detection of amyloid fibril formation. Biochemistry 44: 3718–3724, 2005. 368. Nishida N, Tremblay P, Sugimoto T, Shigematsu K, Shirabe S, Petromilli C, Erpel SP, Nakaoke R, Atarashi R, Houtani T, Torchia M, Sakaguchi S, DeArmond SJ, Prusiner SB, Katamine S. A mouse prion protein transgene rescues mice deficient for the prion protein gene from Purkinje cell degeneration and demyelination. Lab Invest 79: 689–697, 1999. 369. Nonno R, Bari MA, Cardone F, Vaccari G, Fazzi P, Dell’omo G, Cartoni C, Ingrosso L, Boyle A, Galeno R, Sbriccoli M, Lipp HP, Bruce M, Pocchiari M, Agrimi U. Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles. PLoS Pathog 2: e12, 2006. 370. Oesch B, Westaway D, Walchli M, McKinley MP, Kent SB, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE, Weissmann C. A cellular gene encodes scrapie PrP 27–30 protein. Cell 40: 735–746, 1985.
371. Ohhashi Y, Kihara M, Naiki H, Goto Y. Ultrasonication-induced amyloid fibril formation of beta2-microglobulin. J Biol Chem 280: 32843–32848, 2005. 372. Okamoto M, Furuoka H, Horiuchi M, Noguchi T, Hagiwara K, Muramatsu Y, Tomonaga K, Tsuji M, Ishihara C, Ikuta K, Taniyama H. Experimental transmission of abnormal prion protein (PrPsc) in the small intestinal epithelial cells of neonatal mice. Vet Pathol 40: 723–727, 2003. 373. Opie EL. The relation of diabetes mellitus to lesions of the pancreas: hyaline degeneration of the islets of Langerhans. J Exp Med 5: 527–540, 1901. 374. Ott D, Taraborrelli C, Aguzzi A. Novel dominant-negative prion protein mutants identified from a randomized library. Protein Eng Des Sel 21: 623–629, 2008. 375. Owen F, Poulter M, Collinge J, Crow TJ. Codon 129 changes in the prion protein gene in Caucasians. Am J Hum Genet 46: 1215– 1216, 1990. 376. Owen JP, Maddison BC, Whitelam GC, Gough KC. Use of thermolysin in the diagnosis of prion diseases. Mol Biotechnol 35: 161–170, 2007. 377. Packer RJ, Cornblath DR, Gonatas NK, Bruno LA, Asbury AK. Creutzfeldt-Jakob disease in a 20-year-old woman. Neurology 30: 492–496, 1980. 378. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352: 340–342, 1991. 379. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90: 10962– 10966, 1993. 380. Pan T, Li R, Wong BS, Liu T, Gambetti P, Sy MS. Heterogeneity of normal prion protein in two-dimensional immunoblot: presence of various glycosylated and truncated forms. J Neurochem 81: 1092–1101, 2002. 381. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46: 224–233, 1999. 382. Parry HB. Scrapie Disease in Sheep. New York: Academic, 1983. 383. Pattison IH, Jones KM. The possible nature of the transmissible agent of scrapie. Vet Rec 80: 2–9, 1967. 384. Pattison IH, Millson GC. Distribution of the scrapie agent in the tissues of experimentally inoculated goats. J Comp Pathol 72: 233–244, 1962. 385. Pattison IH, Millson GC. Further observations on the experimental production of scrapie in goats and sheep. J Comp Pathol 70: 182–193, 1960. 386. Pattison IH, Millson GC. Scrapie produced experimentally in goats with special reference to the clinical syndrome. J Comp Pathol 71: 101–108, 1961. 387. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364: 527–529, 2004. 388. Peden AH, Ritchie DL, Head MW, Ironside JW. Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 168: 927–935, 2006. 389. Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G, Mehlhorn IR, Legname G, Wormald MR, Rudd PM, Dwek RA, Burton DR, Prusiner SB. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412: 739–743, 2001. 390. Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, Burton DR, DeArmond SJ, Prusiner SB, Scott MR. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 34: 921–932, 2002. 391. Perrier V, Kaneko K, Safar J, Vergara J, Tremblay P, De- Armond SJ, Cohen FE, Prusiner SB, Wallace AC. Dominantnegative inhibition of prion replication in transgenic mice. Proc Natl Acad Sci USA 99: 13079–13084, 2002. AGGREGATION AND INFECTIOUS DISEASE 1149 Physiol Rev VOL 89 OCTOBER 2009 www.prv.org 392. Perry VH, Cunningham C, Boche D. Atypical inflammation in the central nervous system in prion disease. Curr Opin Neurol 15: 349–354, 2002. 393. Piubelli C, Fiorini M, Zanusso G, Milli A, Fasoli E, Monaco S, Righetti PG. Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping. Proteomics 6 Suppl 1: S256–S261, 2006. 394. Polymenidou M, Heppner FL, Pellicioli EC, Urich E, Miele G, Braun N, Wopfner F, Schaetzl H, Becher B, Aguzzi A. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc Natl Acad Sci USA 101: 14670– 14676, 2004. 395. Polymenidou M, Moos R, Scott M, Sigurdson C, Shi YZ, Yajima B, Hafner-Bratkovic I, Jerala R, Hornemann S, Wuthrich K, Bellon A, Vey M, Garen G, James MN, Kav N, Aguzzi A. The POM monoclonals: a comprehensive set of antibodies to nonoverlapping prion protein epitopes. PLoS ONE 3: e3872, 2008. 396. Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, Aguzzi A. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 4: 805–814, 2005. 397. Prinz M, Heikenwalder M, Junt T, Schwarz P, Glatzel M, Heppner FL, Fu YX, Lipp M, Aguzzi A. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425: 957–962, 2003. 398. Prinz M, Heikenwalder M, Schwarz P, Takeda K, Akira S, Aguzzi A. Prion pathogenesis in the absence of Toll-like receptor signalling. EMBO Rep 4: 195–199, 2003. 399. Prinz M, Huber G, Macpherson AJ, Heppner FL, Glatzel M, Eugster HP, Wagner N, Aguzzi A. Oral prion infection requires normal numbers of Peyer’s patches but not of enteric lymphocytes. Am J Pathol 162: 1103–1111, 2003. 400. Prinz M, Montrasio F, Klein MA, Schwarz P, Priller J, Odermatt B, Pfeffer K, Aguzzi A. Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc Natl Acad Sci USA 99: 919–924, 2002. 401. Priola SA, Raines A, Caughey WS. Porphyrin and phthalocyanine antiscrapie compounds. Science 287: 1503–1506, 2000. 402. Prusiner SB. Creutzfeldt-Jakob disease and scrapie prions. Alzheimer Dis Assoc Disord 3: 52–78, 1989. 403. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 216: 136–144, 1982. 404. Prusiner SB, Bolton DC, Groth DF, Bowman KA, Cochran SP, McKinley MP. Further purification and characterization of scrapie prions. Biochemistry 21: 6942–6950, 1982. 405. Prusiner SB, Cochran SP, Downey DE, Groth DF. Determination of scrapie agent titer from incubation period measurements in hamsters. Adv Exp Med Biol 134: 385–399, 1981. 406. Prusiner SB, Cochran SP, Groth DF, Downey DE, Bowman KA, Martinez HM. Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11: 353–358, 1982. 407. Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang SL, DeArmond SJ. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA 90: 10608– 10612, 1993. 408. Prusiner SB, Groth DF, Cochran SP, Masiarz FR, McKinley MP, Martinez HM. Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry 19: 4883–4891, 1980. 409. Prusiner SB, Groth DF, Cochran SP, McKinley MP, Masiarz FR. Gel electrophoresis and glass permeation chromatography of the hamster scrapie agent after enzymatic digestion and detergent extraction. Biochemistry 19: 4892–4898, 1980. 410. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35: 349–358, 1983. 411. Prusiner SB, McKinley MP, Groth DF, Bowman KA, Mock NI, Cochran SP, Masiarz FR. Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci USA 78: 6675–6679, 1981. 412. Prusiner SB, Scott M, Foster D, Pan KM, Groth D, Mirenda C, Torchia M, Yang SL, Serban D, Carlson GA, Hoppe PC, Westaway D, De Armond SJ. Transgenetic studies implicate interac-
Page 1 and 2: Prions: Protein Aggregation and Inf
Page 3 and 4: suggesting that CJD was also a gene
Page 5 and 6: egion in mouse chromosome 2 (479).
Page 7 and 8: merized into rod-shaped particles w
Page 9 and 10: hosts, exhibit distinct prion-disea
Page 11 and 12: eported that polyglutamine aggregat
Page 13 and 14: ogy, and perhaps even to devising t
Page 15 and 16: parietal cortex, of all animals (64
Page 17 and 18: appears to be a direct relationship
Page 19 and 20: cases in Colorado and Wyoming, wher
Page 21 and 22: all fCJD, the clinicopathological d
Page 23 and 24: were still present in 7 / mice. In
Page 25 and 26: generation and maintenance of FDCs
Page 27 and 28: including the kidney. In fact, in v
Page 29 and 30: spleens of sCJD patients (183) indi
Page 31 and 32: Congo red (98), amphotericin B, ant
Page 33 and 34: despite these promising results, Cp
Page 35 and 36: enate diluted in plasma, thereby yi
Page 37 and 38: 36. Banks WA, Niehoff ML, Adessi C,
Page 39 and 40: Jakob disease in England and Wales
Page 41 and 42: 213. Heppner FL, Greter M, Marino D
Page 43: 296. Legname G, Nguyen HO, Peretz D
Page 47 and 48: 453. Shmerling D, Hegyi I, Fischer

Prions: Protein Aggregation and Infectious Diseases - Physiological ...

Create successful ePaper yourself

Delete template?

Save as template?